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Received May 24, 2015; accepted December 17, 2015AbstractBackground: Acinetobacter baumannii has become one of the most serious causative agents of nosocomial infections due to its significant ability
to survive on hospital surfaces. It is mainly an emerging opportunistic pathogen infecting patients in intensive care units. This study was aimed to
identify the clinical isolates of A. baumannii and to investigate their heterogeneity using polymerase chain reaction (PCR)-based typing methods.
Methods: A total of 197 nonduplicate isolates recovered from a wide range of clinical samples were subjected to conventional cultural and
biochemical tests. For those isolates that were preliminary identified as A. baumannii, rpoB-based PCR with subsequent restriction fragment
length polymorphism (RFLP) using two restriction enzymes (TagI and HaeIII) was performed to investigate the genetic diversity of the strains
and their presumptive relationships with different clinical presentation of the disease caused by this pathogen.
Results: In total, 50 isolates (25.4%)were identified asA. baumannii using conventional phenotypicmethods with subsequent confirmation by rpoB
sequencing. RFLP analysis demonstrated five different restriction enzyme patterns, designated as AeE clusters. Most A. baumannii isolates were
categorized under Cluster A (32%). We found no significant relationship between clinical presentation and the clustering of the isolates.
Conclusion: This study showed that the rpoB region possesses high discriminatory power to identify the isolates to the species level. This marker
showed high interspecies variability that might be useful for strain typing. The results also suggest the possibility of the existence of a pre-
dominant clone of A. baumannii among infected patients in Iran.
Copyright © 2016, the Chinese Medical Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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the past 20 years, Acinetobacter species have emerged as
opportunistic pathogens that are associated with severe
hospital-acquired infections.1,2 In particular, among the
various species of this genus, Acinetobacter baumannii is
responsible for a significant proportion of nosocomial in-
fections.3 The management of infections caused by Acineto-
bacter baumannii is greatly hindered by its intrinsic and
acquired resistance to a wide variety of antimicrobial agents.
In addition to this, the number of multidrug-resistant strains
has increased during the past two decades.4 Therefore, A.sevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
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pathogens for health-care institutions globally. To control the
spread of A. baumannii in the hospital setting, it is necessary
to identify potential reservoirs of the organism and the modes
of transmission. In addition, to distinguish A. baumannii
strains involved in the outbreaks from epidemiologically un-
related strains, a comparison of isolates at the subspecies level
is required by application of molecular typing methods.2,5
There are several typing methods for Acinetobacter spp.,
including ribotyping, polymerase chain reaction (PCR) hy-
bridization with species-specific probes, pulse field gel elec-
trophoresis, and random amplified polymorphic DNA
typing.6,7 The main disadvantage of these typing methods is
low reproducibility, especially in terms of global molecular
epidemiology. Using sequence-based typing such as single or
multilocus or whole-genome sequencing provides more reli-
able data to compare strain information from a local point of
view or globally. However, high cost is the main disadvantage
of sequence-based typing in developing countries.6,8 From this
point of view, definitive identification of A. baumannii strains
and investigation of their heterogeneity will be of value for
both clinical studies and molecular epidemiology purposes. In
this study, rpoB-based PCR sequencing was evaluated for
definitive identification of A. baumannii strains and investi-
gation of their heterogeneity. The presumptive relationship
between genotypes and clinical presentation of the patients
was also investigated.
2. Methods2.1. Bacterial strains and phenotypic testsA total of 197 nonduplicate isolates from a wide range of
clinical samples from laboratories of the university teaching
hospitals in Ahvaz and Tehran, Iran, were collected from
November 2011 to January 2013. The preliminary proposal of
the work was reviewed and approved by the Institutional Re-
view and Ethics Board of the Ahvaz Jundishapur University of
Medical Sciences, Ahvaz, Iran. We also received necessary
permission for sample collection and starting the work. The
sources of clinical samples and patients' medical histories are
summarized in Table 1. The isolates were all those identified
as Acinetobacter spp. based on the results of preliminary
conventional phenotypic tests including growth on MacCon-
key agar, sugar fermentation, motility, catalase and oxidase
tests, and other standard recommended tests.9,10 For definitive
identification of these isolates to the species level, molecular
methods were used in the next step.2.2. Molecular methodsThe isolates were identified to the species level using
species-specific rpoB gene-based PCR as previously
described.11 In brief, a 350-bp fragment of the rpoB gene was
amplified from each isolate using two primers of 696F (50-
TAY CGY AAA GAY TTG AAA GAA G-30) and 1093R (50-
CMA CAC CYT TGT TMC CRT CA-30). To investigate theheterogeneity of A. baumannii isolates, restriction fragment
length polymorphism (RFLP) was performed as described by
other investigators, using TagI and HaeIII restriction
endonucleases.122.3. Data analysis of rpoB gene sequencesThe obtained sequences of the rpoB region of each strain
were aligned with the published rpoB region sequences of A.
baumannii strains retrieved from GenBank database using the
JPhydit software package according to the primary structure.13
Comparative analyses of the rpoB region were performed with
the distance matrix, maximum parsimony, and maximum
likelihood methods as implemented in the Molecular Evolu-
tionary Genetics Analysis (MEGA) software version 4.0
(MEGA4) program.14 Tree topologies were tested by bootstrap
analysis on 1000 replicates.
3. Results
A total of 50 isolates (25.4%) were identified as A. bau-
mannii using conventional phenotypic methods with subse-
quent confirmation by rpoB sequencing. These 50 isolates
were recovered from 20 male adults (40%), 14 female adults
(28%), and 16 infants (32%). RFLP analysis demonstrated five
different restriction enzyme patterns, designated as AeE
clusters (designated as “isolate sequence type or seqtype”).
These clusters had 98.2e100% similarity with the A. bau-
mannii type/reference strain in GenBank (CIP70.34). A ma-
jority of A. baumannii isolates were categorized as Cluster A
(32%; Table 2). Twenty-eight isolates (56%) were recovered
from patients with pulmonary disease (Table 1). About half of
the isolates that originated from pulmonary diseases were
classified under Clusters A and B (53.57%), and all the iso-
lates from meningitis cases, though the number was low, were
classified under Clusters C and D. However, significant asso-
ciation between A. baumannii seqtype and age and sex of
patients, pulmonary disease, and other clinical presentations
was not seen.
A dendrogram based on maximum parsimony analysis
reflecting the rpoB sequence-based clustering of all test strains
of A. baumannii is shown in Fig. 1. Within the consensus tree,
five clusters with distinct branches among the A. baumannii
reference strains could be defined. The branches were sup-
ported with the highest bootstrap value (100%).
4. Discussion
In recent times, A. baumannii has emerged as a main
opportunistic pathogen, and there is a high incidence of
morbidity and mortality related to A. baumannii infection
among immunocompromised hospitalized patients.15 This or-
ganism is known for its involvement in hospital outbreaks and
has sometimes caused interinstitutional spread.5 Several
studies have demonstrated the usefulness of rpoB gene
sequencing for the identification and taxonomic classification
of various bacterial species.16,17 This study showed that the
Table 1
Characteristics of 50 clinical isolates of Acinetobacter baumannii from Ahvaz and Tehran, Iran.
Isolates Sample source G/A PMH Main symptoms Section rpoB seqtype sequevars*
1 Endotracheal tube M (42) Chronic bronchitis Fever, chest pain, cough ICU A
8 UC M (44) Kidney infection FUO ICU C
11 Endotracheal tube M (65) COPD Fever, urinary infection ICU E
12 Endotracheal tube M (34) Lung infection Fever, cough ICU A
13 Ulcer Neo Subcutaneous ulcer Dermatitis skin, purulent wound NICU A
16 Endotracheal tube M (32) Chronic bronchitis Fever, cough ICU A
26 Endotracheal tube F (28) Lung infection Fever, cough General A
27 UC F (25) Urinary tract infection Fever, urinary infection, dysuria ICU A
29 Blood Neo Pneumonia Fever, lung infection NICU E
31 CSF F (29) Brain abscess FUO, headache, septicemia ICU A
35 Urine M (35) Kidney infection FUO ER A
40 Endotracheal tube M (38) Lung infection Fever, cough General A
41 UC Neo Bladder wall infection Fever, urethritis NICU A
45 UC Neo Urinary tract infection Fever, urinary infection NICU B
46 Blood M (15) Pneumonia Fever, lung infection ER A
50 Blood F (38) Brain abscess FUO, septicemia ICU B
51 UC Neo Kidney infection FUO NICU C
53 UC Neo Urinary tract infection Fever, urinary infection NICU A
54 UC M (72) Kidney infection Fever, dysuria General A
55 Blood Neo Brain abscess FUO, septicemia NICU E
58 UC M (28) Bladder wall infection Fever, urethritis, dysuria ICU D
60 BAL M (22) COPD Fever, chest pain, cough ICU E
61 Endotracheal tube F (42) COPD Fever, cough ICU A
63 Endotracheal tube M (20) Pneumonia Fever, cough ICU B
64 Endotracheal tube Neo Lung infection Fever, cough NICU B
65 Endotracheal tube F (68) Pneumonia Fever, chest pain, cough ICU D
66 Pleural effusion M (72) Pneumonia Dyspnea, cough ICU B
69 BAL Neo COPD Fever, cough NICU B
70 Endotracheal tube Neo Lung infection Fever, cough, sputum NICU B
71 Ulcer M (42) DM Swelling left leg, purulent
wound discharge
ICU surgery B
72 Ulcer F (39) Burning ulcer Fever, soft tissue abscess ICU surgery E
73 BAL M (42) Chronic bronchitis Fever, cough ICU B
74 Endotracheal tube M (52) COPD Dyspnea, cough ICU B
76 Blood M (19) Meningitis FUO, headache Surgery C
80 Blood M (22) Meningitis Fever, weight loss, headache ER C
81 CSF F (48) Meningitis Fever, headache, septicemia Surgery C
89 Ulcer M (39) Burning ulcer Swelling left leg, purulent
wound discharge
Swelling left leg, purulent
wound discharge
Surgery C
93 Endotracheal tube F (70) Chronic bronchitis Fever, cough ICUB C
95 BAL M (56) COPD Fever, chest pain, cough ICUB E
104 Endotracheal tube F (35) Chronic bronchitis Fever, chest pain, cough ICUB C
116 Endotracheal tube Neo Pneumonia Fever, cough, dyspnea, cough NICU C
117 Sputum Neo Pneumonia Fever, weight loss, headache NICU D
126 Exudates Neo Burning ulcer Fever, septicemia Neonatal D
129 BAL Neo COPD Cough, thoracic pain, weight loss NICU D
137 Endotracheal tube Neo pneumonia Cough, thoracic pain, weight loss NICU D
150 Endotracheal tube F (32) Pneumonia FUO ICU D
153 CSF F (24) Meningitis Fever, chill, headache ICU D
161 BAL Neo Lung infection Fever, chest pain, weight loss NICU A
313 Endotracheal tube F (25) Pneumonia Fever, cough, chest pain ICUB A
470 Blood F (25) Brain abscess FUO, septicemia ICU B
BAL ¼ bronchoalveolar lavage; COPD ¼ chronic obstructive pulmonary disease; CSF ¼ cerebrospinal fluid; DM ¼ diabetes mellitus; ER ¼ emergency room;
F ¼ female; FUO ¼ fever of unknown origin; G/A ¼ gender/age; ICU ¼ intensive care unit; M ¼ male; Neo ¼ neonatal; NICU ¼ neonatal intensive care unit;
PMH ¼ past medical history; UC ¼ urine culture.
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Table 2




Isolates and designation HaeIII TaqI
1,a 26,a 40,a 41,a 161,a 313,a 12, 13, 16, 27, 31, 35, 46, 53, 54, 61 100/170/220/250/300/400 100/220/300/320/480 100 A
45,a 50,a 470,a 63, 64, 66, 69, 70, 71, 73, 74 100/170/220/250/300/400 220/300/320/450 99 B
8,a 51,a 76, 80, 81, 89, 93, 104, 116 100/170/220/250/300/400 220/300/320/460 99.7 C
58,a 65,a 117, 126, 129, 137, 150, 153 100/170/220/250/300/400 220/300/320/480/500 99.5 D
11,a 29,a 55,a 60,a 95,a 72 100/170/220/250/300/400 220/300/320/470 98.2 E
RFLP ¼ restriction fragment length polymorphism.
a Representative of clinical isolates of Acinetobacter baumannii to drawing tree.
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clinical isolates of this pathogen to the species level and is of
value for heterogeneity analysis. Our findings also suggest that
a large variety of A. baumannii seqtypes may be responsible
for causing diseases in humans, of which certain seqtypes
seem to be more predominant. In our study, we identified and
constructed phylogenetic trees incorporating 50 genospecies
of A. baumannii based on the partial rpoB sequences following
the RFLP analysis. RFLP demonstrated five different restric-
tion enzyme patterns, designated as AeE clusters (seqtypes),
and showed homogeneous grouping of A. baumannii.Fig. 1. Distance matrix tree showing the divergence of rpoB sequences of the c
occupied by residues were used for the calculation of binary distance values. The
maximum parsimony and maximum-likelihood analyses. The bar represents 0.1 esFrom the total tested isolates that were initially identified as
Acinetobacter spp. by phenotypic tests, only a small number
was actually confirmed to be A. baumannii by a subsequent
molecular examination. Although, in general, phenotypic tests
are not reliable enough for the identification of Acinetobacter
spp. isolates to the species level,18 these tests exceptionally
offer high sensitivity in identification of A. baumannii strains.
This study showed that it is possible to achieve 100% confir-
mation of the isolates recovered (25.4%) as belonging to A.
baumannii by application of confirmatory rpoB-based PCR
followed by subsequent sequencing. The Acinetobacter spp.linical isolates of Acinetobacter baumannii. All alignment positions that are
topology of the tree was evaluated and corrected according to the results of
timated sequence divergence.
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significant report, conducted by Rahbar et al19 from the
Reference Health Laboratory of Iran, demonstrated the isola-
tion of 88 isolates of A. baumannii in a 1-year survey in a
reference hospital in Tehran. In another similar study, Rahbar
and Hajia20 reported the isolation rate of Acinetobacter spp.
from nosocomial infections to be 3e6%. Moreover, in other
similar studies, 78% and 8.8% of isolates recovered were,
respectively, confirmed as A. baumannii by application of
molecular techniques,21,22 but these rates were not similar to
that of our study. The difference in the obtained rates among
these studies may be explained by the type of clinical sample,
the methods adopted for sample processing and DNA extrac-
tion, and other factors that affect the rate of positivity.
In this work, the A. baumannii strains were categorized into
five different clusters by application of the RFLP technique.
Our study result was concordant with that of Karah et al,22
who also reported five clusters for the A. baumannii isolates
recovered on the basis of rpoB PCR and RFLP analysis.
However, in the study by Gundi et al,16 among the 32 rpoB
seqtypes identified for the Acinetobacter spp., A. baumannii
strains were grouped into 14 distinct clusters, which was more
discriminative than our study or the clustering presented by
Karah et al.22 By contrast, in the study by Turton et al,21 only
three clusters were generated, showing less heterogeneity
among their A. baumannii isolates. The confirmation of A.
baumannii identification and clustering in our study and other
mentioned works were achieved by comparing similarities of
up to 97e100% with the A. baumannii reference strain.
However, this similarity was reported to be wider, 77e100%,
in the study by Turton et al.21
The species variation among A. baumannii strains revealed
by RFLP enabled us to investigate the correlation between
different seqtypes with demographic information and clinical
presentation of the patients. Although the majority of patients
who entered the study had some pulmonary complications
and, from ~56% of these patients, strains belonging to A.
baumannii seqtypes A and B were isolated, we could not find a
significant correlation between the A. baumannii seqtype and
clinical complication or age and sex of the patients.
In conclusion, this study showed that the rpoB region
possesses high discriminatory power to identify the isolates to
the species level. This marker also showed high interspecies
variability when combined with the RFLP technique, which
might be useful for strain typing. The results also suggest the
possibility of the existence of predominant clones of A. bau-
mannii affecting patients in Iran. Although some results in this
study did not show statistical significance, it still provides
groundwork for future studies.
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